Related Experiment Videos
Studies of risk factors for aminoglycoside nephrotoxicity
Abstract:
The epidemiology of aminoglycoside-induced nephrotoxicity is not fully understood. Experimental studies in healthy human volunteers indicate aminoglycosides cause proximal tubular damage in most patients, but rarely, if ever, cause glomerular or tubular dysfunction. Clinical trials of aminoglycosides in seriously ill patients indicate that the relative risk for developing acute renal failure during therapy ranges from 8 to 10 and that the attributable risk is 70% to 80%. Further analysis of these data suggests that the duration of therapy, plasma aminoglycoside levels, liver disease, advanced age, high initial estimated creatinine clearance and, possibly, female gender all increase the risk for nephrotoxicity. Other causes of acute renal failure, such as shock, appear to have an additive effect. Predictive models have been developed from these analyses that should be useful for identifying patients at high risk. These models may also be useful in developing insights into the pathophysiology of aminoglycoside-induced nephrotoxicity.
Insights
Aminoglycoside antibiotics can cause kidney damage (nephrotoxicity), particularly in seriously ill patients. Risk factors include therapy duration, drug levels, and patient age, aiding in high-risk patient identification.
Area of Science:
- Nephrology
- Pharmacology
- Clinical Toxicology
Background:
- Aminoglycoside-induced nephrotoxicity epidemiology requires further elucidation.
- Experimental data suggest proximal tubular damage, but minimal glomerular/tubular dysfunction in healthy volunteers.
- Clinical trials reveal significant acute renal failure risk in critically ill patients.
Purpose of the Study:
- To analyze risk factors for aminoglycoside-induced nephrotoxicity.
- To develop predictive models for identifying high-risk patients.
- To gain insights into the pathophysiology of drug-induced kidney injury.
Main Methods:
- Analysis of clinical trial data from seriously ill patients receiving aminoglycosides.
- Statistical modeling to identify risk factors and develop predictive algorithms.
- Review of experimental studies in human volunteers.
Main Results:
- Relative risk for acute renal failure ranges from 8 to 10; attributable risk is 70-80%.
- Key risk factors identified: duration of therapy, plasma drug levels, liver disease, advanced age, high creatinine clearance, and possibly female gender.
- Additive effects observed with other acute renal failure causes like shock.
Conclusions:
- Predictive models can identify patients at high risk for aminoglycoside nephrotoxicity.
- Understanding risk factors enhances clinical management and patient safety.
- Further research into predictive models may illuminate nephrotoxicity mechanisms.